Improving single-agent chemoresistance risk identification in gestational trophoblastic neoplasia

被引：0
作者：
Ferrandina, Gabriella [1 ,2 ]
Scambia, Giovanni [1 ,2 ]
机构：
[1] Fdn Policlin Univ A Gemelli, Dept Salute Donna & Bambino & Salute Pubbl, IRCCS, UOC Ginecol Oncol, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Inst Ginecol & Ostetr, Rome, Italy
来源：
LANCET ONCOLOGY | 2021年 / 22卷 / 08期
关键词：
MANAGEMENT; DISEASE; TUMORS;
D O I：
10.1016/S1470-2045(21)00327-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1054 / 1056
页数：3
相关论文
共 10 条
  • [1] Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study
    Braga, Antonio
    Paiva, Gabriela
    Ghorani, Ehsan
    Freitas, Fernanda
    Velarde, Luis Guillermo Coca
    Kaur, Baljeet
    Unsworth, Nick
    Lozano-Kuehne, Jingky
    Esteves, Ana Paula Vieira dos Santos
    Filho, Jorge Rezende
    Amim Jr, Joffre
    Aguiar, Xianne
    Sarwar, Naveed
    Elias, Kevin M.
    Horowitz, Neil S.
    Berkowitz, Ross S.
    Seckl, Michael J.
    [J]. LANCET ONCOLOGY, 2021, 22 (08) : 1188 - 1198
  • [2] Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide
    Braga, Antonio
    Mora, Paulo
    de Melo, Andreia Cristina
    Nogueira-Rodrigues, Angelica
    Amim-Junior, Joffre
    Rezende-Filho, Jorge
    Seckl, Michael J.
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2019, 10 (02): : 28 - 37
  • [3] Effective anti-programmed cell death 1 treatment for chemoresistant gestational trophoblastic neoplasia
    Choi, Min Chul
    Oh, Jisu
    Lee, Chan
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 121 : 94 - 97
  • [4] Optimal management of low-risk gestational trophoblastic neoplasia
    Goldstein, Donald P.
    Berkowitz, Ross S.
    Horowitz, Neil S.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1293 - 1304
  • [5] Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society
    Kohorn, EI
    Goldstein, DP
    Hancock, BW
    Kim, SJ
    Lurain, JR
    Newlands, E
    Soper, JT
    Wong, LC
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (01) : 84 - 88
  • [6] Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease
    Lok, Christianne
    van Tromme, Nienke
    Massuger, Leon
    Golfie, Francois
    Seckl, Michael
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 130 : 228 - 240
  • [7] Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia
    Lurain, John R.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (01) : 11 - 18
  • [8] Effects of Single-Agent and Combination Chemotherapy for Gestational Trophoblastic Tumors on Risks of Second Malignancy and Early Menopause
    Savage, Philip
    Cooke, Rosie
    O'Nions, Jenny
    Krell, Jon
    Kwan, Amy
    Camarata, Michelle
    Dancy, Gairin
    Short, Dee
    Seckl, Michael J.
    Swerdlow, Anthony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (05) : 472 - U132
  • [9] Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009
    Sita-Lumsden, A.
    Short, D.
    Lindsay, I.
    Sebire, N. J.
    Adjogatse, D.
    Seckl, M. J.
    Savage, P. M.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 107 (11) : 1810 - 1814
  • [10] Treatment of low-risk gestational trophoblastic neoplasia
    Winter, Matthew C.
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2021, 74 : 67 - 80
1